WRI 36.70 Weingarten Realty Investors $WRI Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 3:58 PM

WRI 36.70 Weingarten Realty Investors $WRI Hit a 52 week high of 36.80 Currently at 36.70 -0.26 -0.70% With a day low of 36.61 and a total volume of 89,246.

WRI Weingarten Realty Investors Recent Headline News

11.4% Return Seen to Date on SmarTrend Weingarten Realty Investors Call (WRI)
Comtex SmarTrend(R) - Tue Nov 11, 10:08AM CST
SmarTrend identified an Uptrend for Weingarten Realty Investors (NYSE:WRI) on October 9th, 2014 at $32.93. In approximately 1 month, Weingarten Realty Investors has returned 11.45% as of today's recent price of $36.70.
WRI: 36.59 (-0.37)

InsiderInsights.com Daily Round Up 11/6/14: Chimerix, Biolase, Barrett Business Services, Ares Capital
InsiderInsights - at Seeking Alpha - Fri Nov 07, 1:06PM CST

73.77 (-0.59), CBG: 32.64 (+0.83), PBFX: 25.30 (-0.15), LLY: 68.09 (-0.26), RL: 171.06 (-0.86), GOOG: 548.94 (+1.45), AER: 44.19 (+0.02), DO: 36.74 (-0.73), TPVG: 14.62 (-0.07), ARCC: 16.31 (-0.02), CMRX: 32.56 (+0.74), OPK: 8.50 (-0.13), BIOL: 2.36 (+0.05), WRI: 36.59 (-0.37), BBSI: 23.14 (-1.14), CUDA: 34.46 (+1.31), ACGL: 57.26 (unch), KPTI: 42.85 (+0.17)

Weingarten Realty Investors Has Returned 12.1% Since SmarTrend Recommendation (WRI)
Comtex SmarTrend(R) - Tue Nov 04, 9:28AM CST
SmarTrend identified an Uptrend for Weingarten Realty Investors (NYSE:WRI) on October 9th, 2014 at $32.93. In approximately 4 weeks, Weingarten Realty Investors has returned 12.09% as of today's recent price of $36.91.
WRI: 36.59 (-0.37)

Weingarten Realty's (WRI) CEO Drew Alexander on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 4:08PM CDT

WRI: 36.59 (-0.37)

More on Weingarten Realty Q3 results
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 5:35PM CDT

WRI: 36.59 (-0.37)

Weingarten Realty beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 5:22PM CDT

WRI: 36.59 (-0.37)

Weingarten Realty reports 3Q results
Automated Insights - Thu Oct 23, 4:30PM CDT
HOUSTON (AP) _ Weingarten Realty Investors (WRI) on Thursday reported a key measure of profitability in its third quarter. The results beat Wall Street expectations.
WRI: 36.59 (-0.37)

Weingarten Realty Reports Same Property NOI Increase of 3.8% and Increases FFO Guidance
Business Wire - Thu Oct 23, 3:07PM CDT
Weingarten Realty (NYSE: WRI) announced today the results of its operations for the quarter ended September 30, 2014. The supplemental financial package with additional information can be found on the Company's website under the Investor Relations tab.
WRI: 36.59 (-0.37)

Weingarten Realty Investors Shares Up 9.2% Since SmarTrend's Buy Recommendation (WRI)
Comtex SmarTrend(R) - Thu Sep 04, 5:03PM CDT
SmarTrend identified an Uptrend for Weingarten Realty Investors (NYSE:WRI) on April 24th, 2014 at $30.89. In approximately 4 months, Weingarten Realty Investors has returned 9.23% as of today's recent price of $33.74.
WRI: 36.59 (-0.37)

Weingarten Realty Investors Announces Third Quarter Earnings Release and Conference Call Dates
Business Wire - Tue Sep 02, 6:00AM CDT
Weingarten Realty Investors (NYSE:WRI) announced today that its third quarter 2014 earnings will be released after the market closes on Thursday, October 23, 2014. Senior Management will host our quarterly earnings conference call on Friday, October 24, 2014 at 10:00 a.m. Central Time.
WRI: 36.59 (-0.37)

Weingarten Realty Investors Has Returned 9.8% Since SmarTrend Recommendation (WRI)
Comtex SmarTrend(R) - Thu Aug 28, 9:35AM CDT
SmarTrend identified an Uptrend for Weingarten Realty Investors (NYSE:WRI) on April 24th, 2014 at $30.89. In approximately 4 months, Weingarten Realty Investors has returned 9.84% as of today's recent price of $33.93.
WRI: 36.59 (-0.37)

Weingarten Realty's Transformed Portfolio Produces Same Property NOI Increase of 3.5%
Business Wire - Thu Jul 24, 3:06PM CDT
Weingarten Realty (NYSE: WRI) announced today the results of its operations for the quarter ended June 30, 2014. The supplemental financial package with additional information can be found on the Company's website under the Investor Relations tab.
WRI: 36.59 (-0.37)

Financial Arrangements, Dividends, Upcoming Results, and New Contracts - Analyst Notes on Ryman Hospitality Properties, W.P. Carey, Weingarten Realty, Duke Realty and Two Harbors Investment
PR Newswire - Thu Jun 26, 5:20AM CDT
Today, Analysts Review released its analysts' notes regarding Ryman Hospitality Properties, Inc. (NYSE: RHP), W.P. Carey Inc. (NYSE: WPC), Weingarten Realty Investors (NYSE: WRI), Duke Realty (NYSE: DRE) and Two Harbors Investment Corp. (NYSE: TWO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4134-100free.
DRE: 19.70 (+0.11), TWO: 10.17 (unch), WRI: 36.59 (-0.37), WPC: 67.16 (-0.01), RHP: 50.29 (+0.28)

Regency Centers Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 5:25PM CDT
Shares of Regency Centers Corporation (REG) reached a 52-week high of $55.94 during the trading session on Friday, Jun 20, 2014.
WRI: 36.59 (-0.37), LHO: 39.29 (-0.19), REG: 62.18 (+0.08), ELS: 48.79 (-0.78)

5 Retail Stocks to Trade for Gains in June
at The Street - Tue Jun 17, 7:22AM CDT
Retail is one of the sectors best-positioned to rally into the second half of the year.
AAP: 144.96 (-0.21), GME: 42.40 (-0.34), WRI: 36.59 (-0.37), SIG: 120.86 (-1.54), AN: 57.81 (-0.09)

Public Offerings, Appointments, New Initiatives, and Technical Updates - Analyst Notes on ARCP, Goldman Sachs, DDR, Navient and Weingarten Realty Investors
PR Newswire - Mon Jun 16, 4:10AM CDT
Today, Analysts Review released its analysts' notes regarding American Realty Capital Properties, Inc. (NASDAQ: ARCP), The Goldman Sachs Group, Inc. (NYSE: GS), DDR Corp. (NYSE: DDR), Navient Corporation (NASDAQ: NAVI) and Weingarten Realty Investors (NYSE: WRI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3313-100free.
DDR: 18.47 (-0.05), GS: 191.79 (-0.01), WRI: 36.59 (-0.37), ARCP: 8.70 (+0.20), NAVI: 20.32 (+0.12)

Weingarten Realty Investors Announces Second Quarter Earnings Release and Conference Call Dates
Business Wire - Fri Jun 13, 7:00AM CDT
Weingarten Realty Investors (NYSE:WRI) announced today that its second quarter 2014 earnings will be released after the market closes on Thursday, July 24, 2014. Senior Management will host our quarterly earnings conference call on Friday, July 25, 2014 at 10:00 a.m. Central Time.
WRI: 36.59 (-0.37)

Weingarten Realty promotes Karl Brinkman and Terri Klages to responsible roles
M2 - Fri Mar 14, 7:00AM CDT
Owner, manager and developer of shopping centres Weingarten Realty Investors (NYSE:WRI) disclosed on Thursday the promotion of Karl Brinkman as Area vice president of Leasing and Terri Klages as Divisional vice president and assistant controller.
WRI: 36.59 (-0.37)

Weingarten Realty Announces Promotions
Business Wire - Thu Mar 13, 10:29AM CDT
Weingarten Realty Investors (NYSE:WRI) announced today the promotion of Karl Brinkman to Area Vice President of Leasing and Terri Klages to Divisional Vice President / Assistant Controller.
WRI: 36.59 (-0.37)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Honeywell Aerospace Faces Class Action: Deadline Looms

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....